vs
Side-by-side financial comparison of Karyopharm Therapeutics Inc. (KPTI) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
UNITY BANCORP INC is the larger business by last-quarter revenue ($35.3M vs $34.1M, roughly 1.0× Karyopharm Therapeutics Inc.). UNITY BANCORP INC runs the higher net margin — 43.9% vs -299.9%, a 343.8% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs 11.6%). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs 1.4%).
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
KPTI vs UNTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.1M | $35.3M |
| Net Profit | $-102.2M | $15.5M |
| Gross Margin | — | — |
| Operating Margin | -52.4% | 55.8% |
| Net Margin | -299.9% | 43.9% |
| Revenue YoY | 11.6% | 24.2% |
| Net Profit YoY | -232.0% | 34.5% |
| EPS (diluted) | $-7.02 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.1M | $35.3M | ||
| Q3 25 | $44.0M | $32.8M | ||
| Q2 25 | $37.9M | $34.4M | ||
| Q1 25 | $30.0M | $29.4M | ||
| Q4 24 | $30.5M | $28.4M | ||
| Q3 24 | $38.8M | $27.7M | ||
| Q2 24 | $42.8M | $25.5M | ||
| Q1 24 | $33.1M | $25.6M |
| Q4 25 | $-102.2M | $15.5M | ||
| Q3 25 | $-33.1M | $14.4M | ||
| Q2 25 | $-37.3M | $16.5M | ||
| Q1 25 | $-23.5M | $11.6M | ||
| Q4 24 | $-30.8M | $11.5M | ||
| Q3 24 | $-32.1M | $10.9M | ||
| Q2 24 | $23.8M | $9.5M | ||
| Q1 24 | $-37.4M | $9.6M |
| Q4 25 | -52.4% | 55.8% | ||
| Q3 25 | -34.6% | 57.5% | ||
| Q2 25 | -64.3% | 62.6% | ||
| Q1 25 | -110.8% | 52.6% | ||
| Q4 24 | -102.4% | 51.0% | ||
| Q3 24 | -67.8% | 52.7% | ||
| Q2 24 | -65.7% | 49.3% | ||
| Q1 24 | -101.9% | 50.0% |
| Q4 25 | -299.9% | 43.9% | ||
| Q3 25 | -75.2% | 43.8% | ||
| Q2 25 | -98.2% | 48.0% | ||
| Q1 25 | -78.2% | 39.5% | ||
| Q4 24 | -100.8% | 40.5% | ||
| Q3 24 | -82.7% | 39.4% | ||
| Q2 24 | 55.6% | 37.1% | ||
| Q1 24 | -112.8% | 37.5% |
| Q4 25 | $-7.02 | $1.52 | ||
| Q3 25 | $-3.82 | $1.41 | ||
| Q2 25 | $-4.32 | $1.61 | ||
| Q1 25 | $-2.77 | $1.13 | ||
| Q4 24 | $-2.33 | $1.13 | ||
| Q3 24 | $-3.85 | $1.07 | ||
| Q2 24 | $-2.97 | $0.92 | ||
| Q1 24 | $-4.85 | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-292.9M | $345.6M |
| Total Assets | $108.4M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.5M | — | ||
| Q3 25 | $37.7M | — | ||
| Q2 25 | $38.7M | — | ||
| Q1 25 | $38.8M | — | ||
| Q4 24 | $62.5M | — | ||
| Q3 24 | $72.8M | — | ||
| Q2 24 | $84.8M | — | ||
| Q1 24 | $30.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-292.9M | $345.6M | ||
| Q3 25 | $-269.3M | $334.0M | ||
| Q2 25 | $-238.9M | $319.8M | ||
| Q1 25 | $-205.9M | $306.1M | ||
| Q4 24 | $-186.0M | $295.6M | ||
| Q3 24 | $-159.6M | $284.3M | ||
| Q2 24 | $-132.1M | $273.4M | ||
| Q1 24 | $-169.0M | $266.8M |
| Q4 25 | $108.4M | $3.0B | ||
| Q3 25 | $96.2M | $2.9B | ||
| Q2 25 | $104.9M | $2.9B | ||
| Q1 25 | $127.7M | $2.8B | ||
| Q4 24 | $164.4M | $2.7B | ||
| Q3 24 | $189.5M | $2.6B | ||
| Q2 24 | $214.0M | $2.6B | ||
| Q1 24 | $204.5M | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.8M | $44.9M |
| Free Cash FlowOCF − Capex | — | $44.3M |
| FCF MarginFCF / Revenue | — | 125.7% |
| Capex IntensityCapex / Revenue | 0.0% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | — | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.8M | $44.9M | ||
| Q3 25 | $-5.9M | $45.5M | ||
| Q2 25 | $-18.7M | $-25.3M | ||
| Q1 25 | $-39.0M | $17.9M | ||
| Q4 24 | $-25.8M | $48.0M | ||
| Q3 24 | $-19.5M | $17.7M | ||
| Q2 24 | $-38.5M | $-8.4M | ||
| Q1 24 | $-43.7M | $15.8M |
| Q4 25 | — | $44.3M | ||
| Q3 25 | — | $45.3M | ||
| Q2 25 | — | $-25.5M | ||
| Q1 25 | — | $17.6M | ||
| Q4 24 | $-25.9M | $47.3M | ||
| Q3 24 | — | $17.5M | ||
| Q2 24 | — | $-8.6M | ||
| Q1 24 | $-43.9M | $15.7M |
| Q4 25 | — | 125.7% | ||
| Q3 25 | — | 138.1% | ||
| Q2 25 | — | -74.2% | ||
| Q1 25 | — | 59.9% | ||
| Q4 24 | -84.7% | 166.5% | ||
| Q3 24 | — | 63.3% | ||
| Q2 24 | — | -33.7% | ||
| Q1 24 | -132.6% | 61.4% |
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 0.2% | 2.4% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | 0.0% | 0.5% | ||
| Q1 24 | 0.6% | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | -1.62× | -0.89× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
UNTY
Segment breakdown not available.
